Neogen Corporation's rapid test for Salmonella enteritidis (SE) has received approval from the National Poultry Improvement Plan (NPIP).
The test kit, Reveal for SE, provides commercial egg producers with a quick and easy method of detecting the dangerous pathogen, as theFDA implements SE-reduction regulations.
“NPIP’s approval further validates our test as an invaluable tool to egg producers, as they comply with the FDA’s new regulations, and seek to further reduce the likelihood of SE-contaminated eggs reaching consumers,” said Ed Bradley, Neogen’s vice president of Food Safety. “Until our introduction of an effective rapid test for SE, the industry had to wait up to seven days for an outside laboratory’s test results. Reveal for SE provides the rapid, accurate answer needed to effectively manage flocks and egg production.” Reveal for SE is the only rapid test available for SE that follows the FDA’s sample enrichment protocol and has received NPIP approval, the company said.
In November, Reveal for SE received AOAC International approval, and in January, the FDA determined Reveal for SE to be equivalent to the FDA’s traditional testing method in accuracy, precision, and sensitivity for detecting SE.